4 results
The primary objective of this study is to evaluate efficacy and safety. Secondary objectives: PK, PK-PD.
Primary: Efficacy of FF/GW642444 100/25 mcg once daily in comparison with that of FP/salmeterol 250/50 mcg twice daily during 24 weeks.Secundary: Safety and tolerability.
The primary goal of this research is to test the proof of concept of the functional prototype of the INES exoskeleton for children with CP in the clinic. In addition,the defined use cases (Donning, Doffing, Sit-to-stand, Stand to sit, Walk) will be…
The primary aim is to investigate the effect of neuromodulation (via UCon) on the symptoms of patients with PGAD. The hypothesis we want to test is whether neuromodulation of the DGN reduces the severity of symptoms of PGAD.